Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Defining reliable disability outcomes in multiple sclerosis.
Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies.
Oligodendrocyte Development and Plasticity.
Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
Physical rehabilitation interventions in nonambulatory people with multiple sclerosis: a systematic review.
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Alpha lipoic acid enhances endogenous peroxisome proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Retrograde trans-synaptic degeneration in MS: A missing link?
(P150) assessment of acute and late toxicities of intracranial stereotactic radiosurgery in multiple sclerosis patients.
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
Drawing on related knowledge to advance multiple sclerosis falls-prevention research.
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis.
Analysis of symptoms, functional impairments, and participation in occupational therapy for individuals with multiple sclerosis.
Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis.
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum.
Speed of word retrieval in multiple sclerosis.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Pages
« first
‹ previous
…
537
538
539
540
541
542
543
544
545
…
next ›
last »